Valuation: Amneal Pharmaceuticals, Inc.

Market Cap 6.52B 5.68B 5.37B 4.87B 9.13B 625B 9.17B 64.27B 24.8B 318B 24.48B 23.94B 1,023B P/E 2026 *
38.2x
P/E 2027 * 23.3x
Enterprise Value 8.83B 7.7B 7.27B 6.61B 12.38B 848B 12.43B 87.13B 33.62B 431B 33.19B 32.45B 1,387B EV / Sales 2026 *
2.8x
EV / Sales 2027 * 2.48x
Free-Float
44.36%
Yield 2026 *
-
Yield 2027 * -
1 day+2.35%
1 week+9.99%
Current month+7.10%
1 month+2.86%
3 months+15.42%
6 months+51.01%
Current year+48.49%
1 week 16.56
Extreme 16.56
19.18
1 month 16.56
Extreme 16.56
19.18
Current year 11.71
Extreme 11.71
19.26
1 year 9.49
Extreme 9.49
19.26
3 years 3.36
Extreme 3.36
19.26
5 years 1.24
Extreme 1.24
19.26
10 years 1.24
Extreme 1.24
24.48
Manager TitleAgeSince
Chief Executive Officer 59 2019-07-31
Chief Executive Officer 54 2019-07-31
Director of Finance/CFO 58 2023-11-06
Director TitleAgeSince
Director/Board Member 59 2023-11-06
Director/Board Member 70 2023-11-06
Director/Board Member 52 2023-11-06
Date Insider Type Main position Quantity % Market Cap. Importance
9/11/26 Exercice

Director

40,890 0.0128%
9/1/26 Don

Executive/Senior Manager

-80,000 0.0251%
8/21/26 Don

Executive/Senior Manager

-152,426 0.0477%
Change 5-day change 1-year change 3-year change Capi.($)
+2.35%+9.99%+90.72%+327.17% 6.37B
+0.04%+3.34%+51.12%+101.82% 1,027B
-0.09%+1.66%+55.02%+66.18% 651B
-0.02%+2.66%+18.91%+71.47% 467B
-1.22%+3.66%+36.44%+38.32% 350B
-0.79%+2.73%+19.03%+25.08% 268B
+0.58%+6.76%+11.13%+16.52% 257B
+1.55%+2.20%+39.81%+46.55% 205B
+0.79%+1.84%-28.27%-56.71% 190B
-0.52%+4.45%+32.12%+98.51% 187B
Average +0.42%+3.66%+32.60%+73.49% 360.85B
Weighted average by Cap. +0.23%+3.02%+35.27%+62.27%

Financials

2026 *2027 *
Net sales 3.15B 2.75B 2.6B 2.36B 4.42B 303B 4.44B 31.11B 12B 154B 11.85B 11.59B 495B 3.44B 3B 2.83B 2.57B 4.82B 330B 4.84B 33.91B 13.09B 168B 12.92B 12.63B 540B
Net income 165M 144M 136M 124M 232M 15.87B 233M 1.63B 630M 8.07B 621M 608M 25.96B 274M 239M 226M 205M 384M 26.31B 386M 2.7B 1.04B 13.38B 1.03B 1.01B 43.04B
Net Debt 2.32B 2.02B 1.91B 1.73B 3.25B 222B 3.26B 22.86B 8.82B 113B 8.71B 8.51B 364B 2B 1.74B 1.64B 1.49B 2.8B 191B 2.81B 19.68B 7.59B 97.34B 7.5B 7.33B 313B
Logo Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
Employees
8,700
Date Price Change Volume
26-09-18 US$18.71 +2.35% 6,619,091
26-09-17 US$18.28 +1.11% 2,816,756
26-09-16 US$18.08 +8.59% 5,124,041
26-09-15 US$16.65 -3.31% 1,793,471
26-09-14 US$17.22 +1.23% 1,596,898
Trader
Investor
Global
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
18.71USD
Average target price
22.00USD
Spread / Average Target
+17.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!